ESR1 and breast carcinoma: ERα, one of the most important targets in human breast cancer therapy, is expressed in MCF-7, BT-474 and T-47D cells, whereas MDA-MB-231 and MDA-MB-468 cells lack the expression of ERα due to epigenetic silencing [23].